PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1127659
PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1127659
The global molecular diagnostics market was valued at US$23,498.2 million in 2022 and is projected to grow at a CAGR of 7.28% during the forecast period 2022-2032.
“The Molecular Diagnostics (MDx) Market Report 2022-2032”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Portable molecular diagnostics include assays and kits used to detect and diagnose diseases in human samples such as throat swabs, blood, serum, and stool. Molecular diagnostics are moving away from centralised laboratories and toward point-of-care molecular testing.
Point-of-care testing, also known as POC testing, is a type of medical testing done at or near the point of care. POC indicates the site of the patient. Sending all samples and specimens away to be processed at medical laboratories means waiting a long time for results. POC tests can greatly improve the management of infectious diseases, especially in developing countries where access to timely medical care faces numerous challenges and the healthcare infrastructure is still old.
The rising prevalence of various diseases has accelerated the development of point-of-care testing methods, fueling the growth of the molecular diagnosis market. According to UNAIDS Data of 2020, approximately 20.6 million people in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa in 2019, 20,000 new HIV cases were reported.
In 2019, an estimated 5.8 million people in Asia Pacific were infected with HIV, with India and China leading the way. According to UNAIDS, approximately 2.1 million people in India were HIV-positive in 2019. The high prevalence of HIV is expected to increase demand for point-of-care diagnostics, hastening the treatment of HIV infection.
The COVID-19 outbreak sparked a race in the diagnostics industry to create novel and rapid coronavirus detection kits. Companies in the infectious diseases segment saw an increase in revenue as a result of the pandemic. For example, Thermo Fisher Scientific reported a 59 percent increase in revenue in April 2021, owing to a 150 percent increase in the diagnostics division. However, as global vaccination rates increase, demand for COVID-19 diagnostics is expected to decrease during the forecast period.
Molecular diagnostics provides precise and effective results and has critical applications in disease diagnosis. However, one of the major impediments to this market is the high cost of molecular tests.
You need to discover how this will impact the molecular diagnostics market today, and over the next 10 years:
This report tells you TODAY how the molecular diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
The report also includes profiles and for some of the leading companies in the Molecular Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies' operations.
Overall world revenue for Molecular Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$23,498.2 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
In summary, our 230+ page report provides you with the following knowledge:
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Molecular Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Rapid GenomEra PCR tests